Showing 3031-3040 of 5771 results for "".
- Opthea Welcomes International Retina Thought Leaders to Its Medical Advisory Boardhttps://modernod.com/news/opthea-welcomes-international-retina-thought-leaders-to-its-medical-advisory-board/2482361/Opthea announced the formation of its Medical Advisory Board, which will comprise of 10 retina thought leaders from countries around the world, including the US, Argentina, Australia, China, France, Germany, and Israel. Chaired by Arshad M. Khanani, MD, MA, FASRS, Chief Medica
- PulseMedica Raises $12 Million to Advance Eye Floater Imaging and Treatment Technologyhttps://modernod.com/news/pulsemedica-raises-12-million-to-advance-eye-floater-imaging-and-treatment-technology/2482360/PulseMedica announced that it has raised an aggregate of $12 million to date in investment as part of their pre-Series A financing round. This investment allowed PulseMedica to generate initial results from their preclinical and clinical studies, and will continue to accelerate the clinical valid
- Perry J. Sternberg Joins Sydnexis as Chief Executive Officerhttps://modernod.com/news/perry-j-sternberg-joins-sydnexis-as-chief-executive-officer/2482358/Sydnexis has announced the appointment of Perry J. Sternberg as Chief Executive Officer and a member of the Board of Directors. Mr. Sternberg is a pharma/biotech executive with more than 30 years in the industry and 15 years in eye care. Immediately prior to joining Sydnexis,
- Nicox Appoints New Chair of the Board and Directorhttps://modernod.com/news/nicox-appoints-new-chair-of-the-board-and-director/2482357/Nicox announced the appointment of the experienced healthcare executive Damian Marron as Chair of the Board of Directors. Marc Le Bozec, an experienced life sciences entrepreneur, was appointed as a new Director of Nicox. Jean-François Labbe is retir
- Claes H. Dohlman, MD, Cornea Research Pioneer and Visionary, Passes Away at 101https://modernod.com/news/claes-h-dohlman-md-cornea-research-pioneer-and-visionary-passes-away-at-101/2482356/Cornea Research Pioneer Claes H. Dohlman, MD, PhD, professor of Ophthalmology, Emeritus, and former Chief and Chair of the Department of Ophthalmology at Mass Eye and Ear and Harvard Medical School (HMS), passed away at the age of 101 on July 14, 2024, Mass Eye and Ear announced on Monday.
- Mount Sinai Ophthalmologists Present New Research at ASRShttps://modernod.com/news/mount-sinai-ophthalmologists-present-new-research-at-asrs/2482355/Ophthalmologists from New York Eye and Ear Infirmary of Mount Sinai in New York City have prepared the following research for the ASRS annual meeting in Stockholm, Sweden, July 17-20. FOUNDERS AWARD WINNER LECTURE Jammi
- Okyo Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101https://modernod.com/news/okyo-pharma-to-initiate-neuropathic-corneal-pain-trial-for-ok-101/2482353/Okyo Pharma announced its plan to advance OK-101 into a phase 2 clinical trial of neuropathic corneal pain which is expected to begin in Q3 2024. This 1-year study is supported by preclinical animal model data and statistically significant pain relief observe
- Hospital in Poland is First Teaching Institution to Use Haag-Streit's Eyesi Indirect Ophthalmoscope ROP Simulatorshttps://modernod.com/news/hospital-in-poland-is-first-teaching-institution-to-use-haag-streits-eyesi-indirect-ophthalmoscope-rop-simulators/2482352/Haag-Streit announced it has enabled trainee ophthalmologists across Poland to become competent in the skills required for effective ROP examination in a lifelike, yet risk-free, environment. The University Clinical Hospital, Poland, will be the first teaching institution globally to use four Eye
- iOR Partners Appoints Lance J. Kugler, MD, to the Role of Strategic Advisory Board Chairmanhttps://modernod.com/news/ior-partners-appoints-lance-j-kugler-md-to-the-role-of-strategic-advisory-board-chairman/2482351/Ophthalmic office-based surgery provider IOR Partners announced that Lance J. Kugler, MD, has been named Chairman of the Strategic Advisory Board. Dr. Kugler opened one of the first OBS suites in 2017 and published a study on the safety of office-based lens surgery in The
- Outlook Therapeutics Receives UK Approval of Lytenava for the Treatment of Wet AMDhttps://modernod.com/news/outlook-therapeutics-receives-uk-approval-of-lytenava-for-the-treatment-of-wet-amd/2482350/Outlook Therapeutics announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Lytenava (bevacizumab gamma), an ophthalmic formulation of bevacizumab for the treatment of wet AMD. Lytenava is the first and only aut